Skip to main content
# Title Research Year
211 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
212 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
213 GEMCITABINE AND CISPLATIN VERSUS METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED AND OR METASTATIC BILHARZIAL UROTHELIAL CARCINOMA OF THE BLADDER IN EGYPT. 2011
214 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
215 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
216 Hypofractionation versus conventional fractionation radiotherapy in the adjuvant treatment of early breast cancer : local tumor control and tissue response 2011
217 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
218 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
219 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011
220 PHASE II STUDY OF THORACIC RADIATION THERAPY WITH CONCURRENT CISPLATIN AND ETOPOSIDE IN UNRESECTABLE NON-SMALL CELL LUNG CANCER 2011